Prefilled Syringes Market Size and Value evaluation By 2026| Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International

Prefilled syringes are ready to use pharmaceutical products used to deliver parenteral medications. These are mainly used for treatment of chronic conditions that require long-term and self-administration of medication. Prefilled syringes are the ideal choice for single-dose drugs, offering easy-to-use fixed dosage options, thereby helping pharmaceutical companies control costs by minimizing drug overfill, minimize microbial contamination and reduce dosing errors. Prefilled syringes make injections easier and safer for both doctors and patients, with the patient always receives the right amount of dosage without complications.

The prefilled syringes market is expected to gain steady traction in the foreseeable future, with the success and growth of biologics, increased global vaccination, increased drug self-administration trend, technological advancements in the manufacture of PFS, and development of advanced PFS would further augment market growth. For instance, Safelia auto injector developed by Nemera in 2017 won the ‘Patient Centricity & Customization’ innovation award at Pharmapack. Safelia is an innovative auto injector for prefilled syringes, available in variable sizes, suitable for large volume and high viscosity delivery through thinner needles.

Download the PDF brochure: www.coherentmarketinsights.com/insight/request-pdf/162

The global prefilled syringes market was valued at US$ 2,805.4 million in 2015 and is expected to witness a CAGR of 11% during the forecast period (2017 – 2025).

Market Dynamics
Minimum environment exposure, easy administration, better patient compliance and 100% bioavailability are the factors expected to drive the prefilled syringes market growth in the forecast period. According to the World Journal of Pharmacy and Pharmaceutical Sciences 2016, more than 3.5 billion prefilled syringes are produced and used annually by patients and healthcare providers for the treatment of broad spectrum of conditions. The technological innovations and developments of prefilled syringes are contributing to the market growth.

Rise in prevalence of chronic diseases globally augments the market growth of the prefilled syringes
Chronic diseases such as type 1 diabetes is encountered among a significant population across the globe, wherein the patients are suggested to undergo regular intra-venous administration of insulin to control their sugar levels inability in natural insulin production. These injections are easy and feasible task with the use of pre-filled syringes that makes the self-administration more convenient and viable. According to Centers for Disease Control and Prevention (CDC), 2014, around 29.1 million people in the U.S. were suffering from diabetes, accounting for 9.3% of the total population.

Market Taxonomy
This report segments the global prefilled syringes market on the basis of drug type, material and geography. On the basis of product type, the prefilled syringes market is categorized into biologics, vaccines, insulin and others. Biologics are further categorized into monoclonal antibodies, blood products and others. Vaccines are further categorized into conjugated vaccines, live attenuated vaccines, recombinant vaccines and others. On the basis of material, the prefilled syringes market is categorized into glass and plastic/polymer. For comprehensive understanding of market dynamics, the global prefilled syringes market is analyzed across key geographical regions namely North America, Latin America, Europe, Asia Pacific, Middle East and Africa. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Key features of the study:

- This report provides in-depth analysis of the prefilled syringes market and its application, market size (US$ Million) and Cumulative Annual Growth Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering 2017 as the base year.
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players.
- It profiles leading players in the global prefilled syringes market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans.
- Key companies covered as a part of this study include Becton Dickinson & Co., Gerresheimer, Medtronic, Baxter International, SCHOTT AG, West Pharmaceuticals, Vetter International, Unilife Corporation, Stevanato Group and Terumo Corporation.

Request For A Sample Copy Of This Research Report: www.coherentmarketinsights.com/insight/request-sample/162

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.